|
|
||||||||
1 Seattle Biomedical Research Institute, 307 Westlake Ave N, Suite 500, Seattle, WA 98109, USA
2 Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA
3 Division of Infectious Diseases, Children's Hospital and Regional Medical Center, 4800 Sand Point Way, Seattle, WA 98105, USA
Correspondence
Arnold L. Smith
arnold.smith{at}sbri.org
Hypermutable bacterial pathogens exist at surprisingly high prevalence and benefit bacterial populations by promoting adaptation to selective environments, including resistance to antibiotics. Five hundred Haemophilus influenzae isolates were screened for an increased frequency of mutation to resistance to rifampicin, nalidixic acid and spectinomycin: of the 14 hypermutable isolates identified, 12 were isolated from cystic fibrosis (CF) sputum. Analysis by enterobacterial repetitive intergenic consensus (ERIC)-PCR and ribotyping identified eight distinct genetic fingerprints. The hypermutable phenotype of seven of the eight unique isolates was associated with polymorphisms in conserved sites of mutS. Four of the mutant mutS alleles were cloned and failed to complement the mutator phenotype of a mutS : : TSTE mutant of H. influenzae strain Rd KW20. Antibiotic susceptibility testing of the hypermutators identified one
-lactamase-negative ampicillin-resistant (BLNAR) isolate with two isolates producing
-lactamase. Six isolates from the same patient with CF, with the same genetic fingerprint, were clonal by multilocus sequence typing (MLST). In this clone, there was an evolution to higher MIC values for the antibiotics administered to the patient during the period in which the strains were isolated. Hypermutable H. influenzae with mutations in mutS are prevalent, particularly in the CF lung environment, and may be selected for and maintained by antibiotic pressure.
-lactamase-negative ampicillin-resistant; CF, cystic fibrosis; ERIC, enterobacterial repetitive intergenic consensus; MLST, multilocus sequence typing; MMR, methyl-directed mismatch repair; PBP, penicillin-binding proteinThe GenBank/EMBL/DDBJ accession numbers for the sequences reported in this paper are AY568590, AY568591, AY568592, AY568593, AY568594, AY568595, AY568596 and AY568597.
This article has been cited by other articles:
![]() |
A. M. Marcobal, D. A. Sela, Y. I. Wolf, K. S. Makarova, and D. A. Mills Role of Hypermutability in the Evolution of the Genus Oenococcus J. Bacteriol., January 15, 2008; 190(2): 564 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Davidsen, H. K. Tuven, M. Bjoras, E. A. Rodland, and T. Tonjum Genetic Interactions of DNA Repair Pathways in the Pathogen Neisseria meningitidis J. Bacteriol., August 1, 2007; 189(15): 5728 - 5737. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Kenna, C. J. Doherty, J. Foweraker, L. Macaskill, V. A. Barcus, and J. R. W. Govan Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis Microbiology, June 1, 2007; 153(6): 1852 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Montanari, A. Oliver, P. Salerno, A. Mena, G. Bertoni, B. Tummler, L. Cariani, M. Conese, G. Doring, and A. Bragonzi Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis Microbiology, May 1, 2007; 153(5): 1445 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perez-Vazquez, F. Roman, S. Garcia-Cobos, and J. Campos Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1566 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. C. Hall and S. K. Henderson-Begg Hypermutable bacteria isolated from humans - a critical analysis. Microbiology, September 1, 2006; 152(Pt 9): 2505 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Macia, N. Borrell, M. Segura, C. Gomez, J. L. Perez, and A. Oliver Efficacy and Potential for Resistance Selection of Antipseudomonal Treatments in a Mouse Model of Lung Infection by Hypermutable Pseudomonas aeruginosa Antimicrob. Agents Chemother., March 1, 2006; 50(3): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Cirz and F. E. Romesberg Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria Antimicrob. Agents Chemother., January 1, 2006; 50(1): 220 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Denamur, O. Tenaillon, C. Deschamps, D. Skurnik, E. Ronco, J. L. Gaillard, B. Picard, C. Branger, and I. Matic Intermediate Mutation Frequencies Favor Evolution of Multidrug Resistance in Escherichia coli Genetics, October 1, 2005; 171(2): 825 - 827. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |